These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 33597970)

  • 1. Case Report: Novel RPGRIP1L Gene Mutations Identified by Whole Exome Sequencing in a Patient With Multiple Primary Tumors.
    Guo J; Yang Y; Ji Z; Yao M; Xia X; Sha X; Huang M
    Front Genet; 2021; 12():620472. PubMed ID: 33597970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
    Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
    BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
    Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing of multiple meningiomas with varying histopathological presentation in one patient revealed distinctive somatic mutation burden and independent clonal origins.
    Sheng HS; Shen F; Zhang N; Yu LS; Lu XQ; Zhang Z; Fang HY; Zhou LL; Lin J
    Cancer Manag Res; 2019; 11():4085-4095. PubMed ID: 31123420
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
    Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
    Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome sequencing of duodenal adenocarcinoma identifies recurrent Wnt/β-catenin signaling pathway mutations.
    Yuan W; Zhang Z; Dai B; Wei Q; Liu J; Liu Y; Liu Y; He L; Zhou D
    Cancer; 2016 Jun; 122(11):1689-96. PubMed ID: 26998897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing to identify novel somatic mutations in squamous cell lung cancers.
    Zheng CX; Gu ZH; Han B; Zhang RX; Pan CM; Xiang Y; Rong XJ; Chen X; Li QY; Wan HY
    Int J Oncol; 2013 Sep; 43(3):755-64. PubMed ID: 23799614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.
    Mendoza-Alvarez A; Guillen-Guio B; Baez-Ortega A; Hernandez-Perez C; Lakhwani-Lakhwani S; Maeso MD; Lorenzo-Salazar JM; Morales M; Flores C
    Front Genet; 2019; 10():439. PubMed ID: 31156702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
    Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
    Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.
    Furukawa T; Sakamoto H; Takeuchi S; Ameri M; Kuboki Y; Yamamoto T; Hatori T; Yamamoto M; Sugiyama M; Ohike N; Yamaguchi H; Shimizu M; Shibata N; Shimizu K; Shiratori K
    Sci Rep; 2015 Mar; 5():8829. PubMed ID: 25743105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
    Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
    Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing identifies a potential TTN mutation in a multiplex family with inguinal hernia.
    Mihailov E; Nikopensius T; Reigo A; Nikkolo C; Kals M; Aruaas K; Milani L; Seepter H; Metspalu A
    Hernia; 2017 Feb; 21(1):95-100. PubMed ID: 27115767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel somatic mutations identified by whole-exome sequencing in muscle-invasive transitional cell carcinoma of the bladder.
    Pan H; Xu X; Wu D; Qiu Q; Zhou S; He X; Zhou Y; Qu P; Hou J; He J; Zhou J
    Oncol Lett; 2016 Feb; 11(2):1486-1492. PubMed ID: 26893765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
    Crago AM; Chmielecki J; Rosenberg M; O'Connor R; Byrne C; Wilder FG; Thorn K; Agius P; Kuk D; Socci ND; Qin LX; Meyerson M; Hameed M; Singer S
    Genes Chromosomes Cancer; 2015 Oct; 54(10):606-15. PubMed ID: 26171757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac Death.
    Zaragoza MV; Fung L; Jensen E; Oh F; Cung K; McCarthy LA; Tran CK; Hoang V; Hakim SA; Grosberg A
    PLoS One; 2016; 11(5):e0155421. PubMed ID: 27182706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients.
    Romero Arenas MA; Fowler RG; San Lucas FA; Shen J; Rich TA; Grubbs EG; Lee JE; Scheet P; Perrier ND; Zhao H
    Surgery; 2014 Dec; 156(6):1351-7; discussion 1357-8. PubMed ID: 25456907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
    Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
    J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing identifies novel mutations in genes responsible for retinitis pigmentosa in 2 nonconsanguineous Chinese families.
    Hu YS; Song H; Li Y; Xiao ZY; Li T
    Int J Ophthalmol; 2019; 12(6):915-923. PubMed ID: 31236346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-exome sequencing in a patient with synchronous triple primary malignancies involving lung cancer: a case report.
    Li D; Yu M; Zhou P; Yang J; Wang Y
    Precis Clin Med; 2020 Dec; 3(4):306-310. PubMed ID: 35692627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
    Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
    J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.